“axl”的搜索结果

23 个项目

每页

设置降序顺序
  1. DS-1205b free base

    Catalog No. A22138
    Quick View
    inhibitor of AXL kinase
    DS-1205b free base is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. 了解更多
  2. ONO-7475

    Catalog No. A22226
    Quick View
    Axl/Mer inhibitor
    ONO-7475 is a potent, selective, and orally active Axl/Mer inhibitor with IC50 values of 0.7 nM and 1.0 nM, respectively. 了解更多
  3. CEP-40783

    Catalog No. A20331
    Quick View
    AXL/c-Met inhibitor
    CEP-40783 is a potent, selective and orally available inhibitor of AXL and c-Met with IC50 values of 7 nM and 12 nM, respectively. 了解更多
  4. BMS 777607

    Catalog No. A21638
    Quick View
    c-Met/Axl/Ron/Tyro3 inhibitor
    BMS 777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, respectively. 了解更多
  5. S49076

    Catalog No. A21407
    Quick View
    MET, AXL/MER, and FGFR1/2/3 inhibitor
    S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3 with IC50 values below 20 nM. 了解更多
  6. Gilteritinib hemifumarate

    Catalog No. A18235
    Quick View
    FLT3/AXL inhibitor
    Gilteritinib hemifumarate is a potent FLT3/AXL inhibitor with IC50 of 0.29 nM/0.73 nM, respectively. 了解更多
  7. R916562

    Catalog No. A19374
    Quick View
    Axl/VEGFR2 抑制剂
    R916562 is an orally active and selective Axl/VEGF-R2 inhibitor with IC50s of 136 nM and 24 nM, respectively. R916562 has anti-angiogenesis and anti-metastasis. 了解更多
  8. Gilteritinib (ASP2215)

    Catalog No. A14411
    Quick View
    FLT3/Axl 抑制剂
    Gilteritinib (ASP2215)是一种有效的FLT3/AXL抑制剂,对具有AML突变或FLT3-ITD和FLT3-D835的AML具有有效的抗白血病活性。 了解更多
  9. XL092

    Catalog No. A22468
    Quick View
    XL092 is an ATP-competitive inhibitor of multiple RTKs including MET, VEGFR2, AXL and MER, with IC50 values in cell-based assays of 15, 1.6, 3.4, and 7.2 nM respectively. 了解更多
  10. Cabozantinib S-malate

    Catalog No. A11349
    Quick View
    multiple receptor tyrosine kinases inhibitor
    Cabozantinib S-malate (XL184 S-malate) is a potent multiple receptor tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively. 了解更多
  11. UNC2541

    Catalog No. A18523
    Quick View
    Mer tyrosine kinase inhibitor
    UNC2541 is a potent and Mer tyrosine kinase (MerTK)-specific inhibitor, binds in the MerTK ATP pocket, with an IC50 of 4.4 nM, more selective over Axl, Tyro3 and Flt3. UNC2541 inhibits phosphorylated MerTK (pMerTK; EC50, 510 nM). 了解更多
  12. Glesatinib hydrochloride

    Catalog No. A16257
    Quick View
    MET/Axl 抑制剂
    Glesatinib hydrochloride是MET和Axl受体酪氨酸激酶途径的抑制剂,当改变时,它们会驱动肿瘤的生长。 了解更多
  13. SGI-7079

    Catalog No. A15864
    Quick View
    Axl 抑制剂
    SGI-7079是一种新型的选择性Axl抑制剂,以剂量依赖的方式抑制肿瘤的生长,并且是克服EGFR抑制剂耐药性的潜在治疗靶标。 了解更多
  14. TP-0903

    Catalog No. A15776
    Quick View
    AXL 抑制剂
    TP-0903是一种有效的选择性Axl激酶抑制剂,IC50为27 nM。 了解更多
  15. R428

    Catalog No. A13741
    Quick View
    Axl 抑制剂
    R428是Axl激酶的选择性小分子抑制剂,在转移性乳腺癌模型中显示出阻断肿瘤扩散和延长生存期的活性。 了解更多
  16. Picropodophyllin

    Catalog No. A12195
    Quick View
    Picropodophyllin是首个靶向口服小分子igf-1受体抑制剂,IC50为1 nM。对胰岛素受体无影响。 了解更多
  17. EMD-1214063

    Catalog No. A11257
    Quick View
    c-Met 抑制剂
    EMD-1214063是MET酪氨酸激酶的抑制剂,IC50为4 nM,作用于c-Met比作用于IRAK4, TrkA, Axl, IRAK1和Mer选择性高200倍以上。具有潜在的抗肿瘤活性。它与MET酪氨酸激酶结合并破坏MET信号转导途径,这可能在过表达该激酶的肿瘤细胞中诱导凋亡。 了解更多
  18. SNS-314

    Catalog No. A10851
    Quick View
    Aurora 抑制剂
    SNS-314 Mesylate是Aurora A,Aurora B和Aurora C的有效和选择性抑制剂,IC50分别为9 nM,31 nM和3 nM。 它对Trk A/B,Flt4,Fms,Axl,c-Raf和DDR2的效力较低。 阶段1。 了解更多
  19. Ningetinib

    Catalog No. A17042
    Quick View
    tyrosine kinase 抑制剂
    Ningetinib是一种多激酶抑制剂,可抑制c-Met,VEGFR2/KDR和Axl,IC50值分别为19、37和11 nM。 了解更多
  20. 2-D08

    Catalog No. A16852
    Quick View
    SUMO 抑制剂
    2-D08是细胞可渗透的,机械上独特的蛋白质sumoylation抑制剂。在生化测定中,它也抑制Axl,IRAK4,ROS1,MLK4,GSK3β,RET,KDR和PI3Kα,IC50值分别为0.49、3.9、5.3、9.8、11、11、17和35 nM。 了解更多
  21. NPS-1034

    Catalog No. A15917
    Quick View
    c-Met 抑制剂
    NPS-1034是双重Met/Axl抑制剂,IC50分别为48 nM和10.3 nM。 了解更多
  22. UNC-2025

    Catalog No. A15904
    Quick View
    Dual MER/FLT3 抑制剂
    UNC-2025是一种有效的且可生物利用的双重MER/FLT3抑制剂,IC50分别为0.74 nM和0.8 nM,选择性是Axl和Tyro3的20倍。 了解更多
  23. LDC1267

    Catalog No. A13003
    Quick View
    TAM Receptor 抑制剂
    LDC1267是一种高选择性TAM(Tyro3,Axl和Mer)激酶抑制剂,对于Tyro3,Axl和Mer的IC50分别小于5 nM/8 nM/29 nM。 了解更多

23 个项目

每页

设置降序顺序
Rewards